File:SputnikVEfficacy001.svg
Size of this PNG preview of this SVG file: 476 × 599 pixels. Other resolutions: 190 × 240 pixels | 381 × 480 pixels | 476 × 600 pixels | 610 × 768 pixels | 813 × 1,024 pixels | 567 × 714 pixels.
Original file (SVG file, nominally 567 × 714 pixels, file size: 10 KB)
|
This is a file from the Wikimedia Commons. The description on its description page there is shown below.
|
Summary
| Description |
English: Sputnik V efficacy for different conditions. Data from: Logunov D. Y. et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. The Lancet. V. 397, P. 671-681. doi:10.1016/S0140-6736(21)00234-8 |
| Date | |
| Source | Own work |
| Author | V1adis1av |
Licensing
I, the copyright holder of this work, hereby publish it under the following license:
This file is licensed under the Creative Commons Attribution-Share Alike 4.0 International license.
- You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
- Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- share alike – If you remix, transform, or build upon the material, you must distribute your contributions under the same or compatible license as the original.
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Dimensions | User | Comment | |
|---|---|---|---|---|
| current | 01:15, 9 April 2021 | 567 × 714 (10 KB) | VBLby9 | Fixed Typo (efficasy -> efficacy) |
File usage
The following page uses this file:
